Association Between Antenatal Exposure to Zika Virus and Anatomical and Neurodevelopmental Abnormalities in Children.
Brain
/ diagnostic imaging
Brazil
/ epidemiology
Child, Preschool
Cohort Studies
Female
Humans
Infant, Newborn
Male
Microcephaly
/ diagnosis
Neurodevelopmental Disorders
/ diagnosis
Neuroimaging
/ methods
Pregnancy
Pregnancy Complications, Infectious
/ diagnosis
Prenatal Exposure Delayed Effects
/ epidemiology
Retrospective Studies
Zika Virus Infection
/ complications
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 07 2020
01 07 2020
Historique:
entrez:
8
7
2020
pubmed:
8
7
2020
medline:
29
12
2020
Statut:
epublish
Résumé
Zika virus (ZIKV) is a mosquito-borne flavivirus recognized as teratogenic since the 2015 to 2016 epidemic. Antenatal ZIKV exposure causes brain anomalies, yet the full spectrum has not been delineated. To characterize the clinical features of ZIKV infection at a pediatric referral center in Rio de Janeiro, Brazil, among children with antenatal ZIKV exposure. Retrospective cohort study conducted from May to July 2019 of a prospective cohort of 296 infants with antenatal ZIKV exposure followed up since December 2015 at a tertiary maternity-pediatric hospital. Zika virus infection during pregnancy. Characterization of clinical features with anthropometric, neurologic, cardiologic, ophthalmologic, audiometric, and neuroimaging evaluations in infancy and neurodevelopmental assessments (Bayley Scales of Infant and Toddler Development, Third Edition) from 6 to 42 months of age, stratified by head circumference at birth (head circumference within the reference range, or normocephaly [NC] vs microcephaly [MC]). Antenatal exposure to ZIKV was confirmed for 219 of 296 children (74.0%) referred to Instituto Fernandes Figueira with suspected ZIKV infection through positive maternal or neonatal polymerase chain reaction analysis or IgM serology results. Of these children, 110 (50.2%) were boys, ages ranged from 0 to 4 years, and 53 (24.2%) had congenital microcephaly. The anomalies observed in ZIKV-exposed children with MC or NC were failure to thrive (MC: 38 of 53 [71.7%]; NC: 73 of 143 [51.0%]), cardiac malformations (MC: 19 of 46 [41.3%]; NC: 20 of 100 [20.0%]), excess nuchal skin (MC: 16 of 22 [72.7%]; NC: 35 of 93 [37.6%]), auditory abnormalities (MC: 13 of 50 [26.0%]; NC: 14 of 141 [9.9%]), and eye abnormalities (MC: 42 of 53 [79.2%]; NC: 28 of 158 [17.7%]). Although they experienced fewer neurologic abnormalities than children born with MC, those with NC also had frequent neurologic abnormalities (109 of 160 [68.1%]), including hyperreflexia (36 of 136 [26.5%]), abnormal tone (53 of 137 [38.7%]), congenital neuromotor signs (39 of 93 [41.9%]), feeding difficulties (15 of 143 [10.5%]), and abnormal brain imaging results (44 of 150 [29.3%]). Among 112 children with NC with Bayley-III evaluations, 72 (64.3%) had average or above-average scores; 30 (26.8%) scored 1 SD below average in at least 1 domain; and 10 (8.9%) scored 2 SD below average in at least 1 domain. Among 112 children with NC, a smaller head circumference at birth was significantly associated with subsequent below-average cognitive scores (U = 499.5; z = -2.833; P = .004) and language scores (U = 235.5; z = -2.491; P = .01). Children without MC who were exposed to ZIKV in utero had a high frequency of anatomical and neurodevelopmental abnormalities. The head circumference at birth for children with NC was associated with neurocognitive development. Recognition of the wide spectrum of clinical phenotypes is critical to ensure early referral to rehabilitative interventions.
Identifiants
pubmed: 32633763
pii: 2767943
doi: 10.1001/jamanetworkopen.2020.9303
pmc: PMC7341180
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e209303Subventions
Organisme : NIAID NIH HHS
ID : R01 AI140718
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI129534
Pays : United States
Organisme : NEI NIH HHS
ID : R21 EY028318
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Lancet Infect Dis. 2016 Jun;16(6):653-660
pubmed: 26897108
N Engl J Med. 2009 Jun 11;360(24):2536-43
pubmed: 19516034
JAMA Neurol. 2016 Dec 1;73(12):1407-1416
pubmed: 27695855
Emerg Infect Dis. 2011 May;17(5):880-2
pubmed: 21529401
MMWR Morb Mortal Wkly Rep. 2017 Mar 31;66(12):329-334
pubmed: 28358795
JAMA Pediatr. 2017 Mar 1;171(3):288-295
pubmed: 27812690
N Engl J Med. 2017 Feb 14;379(13):1234-1243
pubmed: 28195756
BJOG. 2013 Sep;120 Suppl 2:9-26, v
pubmed: 23678873
Infection. 2016 Dec;44(6):695-705
pubmed: 27510169
JAMA Pediatr. 2017 May 1;171(5):478-485
pubmed: 28241263
Arq Bras Oftalmol. 2016 Feb;79(1):1-3
pubmed: 26840156
Science. 2016 May 13;352(6287):816-8
pubmed: 27064148
N Engl J Med. 2016 Mar 10;374(10):951-8
pubmed: 26862926
Trans R Soc Trop Med Hyg. 1952 Sep;46(5):509-20
pubmed: 12995440
Nat Med. 2019 Aug;25(8):1213-1217
pubmed: 31285631
Am J Obstet Gynecol. 2018 Apr;218(4):440.e1-440.e36
pubmed: 29353032
MMWR Morb Mortal Wkly Rep. 2017 Oct 20;66(41):1089-1099
pubmed: 29049277
Mem Inst Oswaldo Cruz. 2015 Jun;110(4):569-72
pubmed: 26061233
Euro Surveill. 2016 Jun 9;21(23):
pubmed: 27311680
MMWR Morb Mortal Wkly Rep. 2016 Jan 29;65(3):59-62
pubmed: 26820244
Childs Nerv Syst. 2018 Jan;34(1):63-71
pubmed: 29110197
Emerg Infect Dis. 2008 Aug;14(8):1232-9
pubmed: 18680646
JAMA Netw Open. 2019 Oct 2;2(10):e1914061
pubmed: 31651970
Emerg Infect Dis. 2016 Jul;22(7):1318-20
pubmed: 27070847
MMWR Morb Mortal Wkly Rep. 2017 Mar 03;66(8):219-222
pubmed: 28253231
Pediatrics. 2018 Oct;142(4):
pubmed: 30213843
Obstet Gynecol. 2017 Jul;130(1):207-212
pubmed: 28594771
PLoS Negl Trop Dis. 2017 Apr 10;11(4):e0005528
pubmed: 28394887
Cell Stem Cell. 2016 May 5;18(5):587-90
pubmed: 26952870
N Engl J Med. 2016 Dec 15;375(24):2321-2334
pubmed: 26943629
Clin Infect Dis. 2017 May 15;64(10):1302-1308
pubmed: 28329257
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
MMWR Morb Mortal Wkly Rep. 2017 Apr 07;66(13):366-373
pubmed: 28384133
MMWR Morb Mortal Wkly Rep. 2016 Dec 02;65(47):1343-1348
pubmed: 27906905
JAMA Pediatr. 2017 Sep 1;171(9):847-854
pubmed: 28715527
Pediatrics. 2016 May;137(5):
pubmed: 27009036
Lancet Infect Dis. 2016 Dec;16(12):1307-1309
pubmed: 27641776
Euro Surveill. 2014 Apr 03;19(13):
pubmed: 24721538
J Clin Microbiol. 2017 Jul;55(7):2127-2136
pubmed: 28446573
Clin Infect Dis. 2020 Jun 10;70(12):2663-2672
pubmed: 31346616
PLoS Negl Trop Dis. 2018 Mar 26;12(3):e0006362
pubmed: 29579059
N Engl J Med. 2018 Dec 13;379(24):2377-2379
pubmed: 30575464
Curr Opin Pediatr. 2018 Feb;30(1):105-116
pubmed: 29176498
Lancet Infect Dis. 2016 Dec;16(12):1356-1363
pubmed: 27641777
Int J Epidemiol. 2003 Aug;32(4):518-26
pubmed: 12913022
AJNR Am J Neuroradiol. 2017 Jul;38(7):1427-1434
pubmed: 28522665
MMWR Morb Mortal Wkly Rep. 2016 Mar 11;65(9):242-7
pubmed: 26963593
JAMA Netw Open. 2019 Jul 3;2(7):e198124
pubmed: 31365112
Emerg Infect Dis. 2016 Jul;22(7):1185-92
pubmed: 27070380
Acta Neuropathol. 2017 Jun;133(6):983-999
pubmed: 28332092